GATC Health Appoints Former Blizzard Entertainment Owner and AI Entrepreneur Bob Davidson to Board of Directors

GATC Health Appoints Former Blizzard Entertainment Owner and AI Entrepreneur Bob Davidson to Board of Directors

Irvine, Calif. – May 28, 2025 – GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, today announced the appointment of Bob Davidson to its board of directors, effective immediately. Davidson brings decades of experience in successfully building and scaling organizations, to the company, further strengthening GATC Health’s leadership as it advances its mission in artificial intelligence-driven health care solutions.

“Bob’s combination of legal expertise, business acumen and proven success in AI-driven enterprises will be invaluable as GATC Health continues to innovate at the intersection of technology and health care,” said Dr. Rahul Gupta, President of GATC Health. “We are excited to welcome him to our board and look forward to his guidance as we expand our impact. This appointment underscores GATC Health’s commitment to visionary leadership and technological excellence.”

Davidson’s distinguished career includes pivotal roles in law andbusiness, as well as entrepreneurial and philanthropic ventures. With a Juris Doctor from George Washington University and an MBA from UCLA, he has served as a patent examiner with the US Patent Office and practiced as a patent and corporate lawyer for leading firms, including TRW and Parsons Corp. before founding Davidson & Associates.

As chairman and CEO of Davidson & Associates, Mr. Davidson acquired Blizzard Entertainment and led the company to a landmark $1.2 billion sale. Blizzard is a premier developer and publisher of some of the industry’s most critically acclaimed and genre-defining video games and multiple Game of the Year award winner. More recently, he founded SpreeAI, a fashion technology company leveraging artificial intelligence, which has reached a pre-revenue valuation of $1.55 billion in just four years.

“GATC Health is helping redefine the biotech and pharmaceutical industries, where safer, more effective drugs are created and tested faster and at lower cost than ever before,” Davidson said. “Our mission is to use our AI platform to accelerate and derisk the various processes—and investment decisions—that result in superior treatments for more diseases, benefiting patients around the world. As a member of the Board, I am committed to increasing shareholder value and guiding GATC to industry leadership.”

In addition to his business career, Davidson has served as director for Pepperdine University and George Washington University and founded the Davidson Institute for Talent Development. The Davidson Institute is a nonprofit operating foundation that has served more than 5,000 profoundly gifted children and young adults through various initiatives, including Davidson Young Scholars program, Fellows Scholarship, and summer programs. One of the Davidson Institute’s programs is The Davidson Academy, the first free public school of its kind for very high achieving middle and high school students. It is located on the University of Nevada, Reno campus, and has been ranked the No. 1 public middle school and high school in the United States.

About GATC Health

GATC Health Corp. is a technology company transforming drug discovery and development through its AI-driven platform and approach. The company’s validated and proprietary Multiomics Advanced Technology™ (MAT) simulates human biochemistry’s billions of interactions to rapidly create novel therapeutics, identify and confirm targets, accelerate development, and derisk drug pipelines by predicting efficacy, safety, and off-target effects.

For more information, visit www.gatchealth.com.